Φορτώνει......
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
Somatostatin analogs (SSA) are well-established antisecretory drugs in functionally active neuroendocrine tumors (NET). Two placebo-controlled trials have recently demonstrated significant improvement of progression-free survival under SSA treatment. Furthermore, somatostatin receptor (SSTR) overexp...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Front Endocrinol (Lausanne) |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Frontiers Media S.A.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5897986/ https://ncbi.nlm.nih.gov/pubmed/29681888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00146 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|